BOSTON, Feb. 23, 2026 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a clinical stage company pioneering immuno-oncology and RNA therapeutics for the treatment of high risk and advanced cancers, today announced the publication of a manuscript titled Template-Directed RIG-I...
Hence then, the article about transcode therapeutics announces publication of preclinical testing of rig i immunotherapeutic candidate supporting further development was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( TransCode Therapeutics Announces Publication of Preclinical Testing of RIG-I Immunotherapeutic Candidate Supporting Further Development )
Also on site :
- ‘For All Mankind’ Star Joel Kinnaman and Creators Unpack [SPOILER]’s Death and Why It Was ‘the Hardest Ending to Craft’
- Natomas High School student shot near campus in Sacramento, police say
- ‘Good for Russia, good for China, bad for America’: How the Iran war is reshaping global economies and power